Laburthe M, Prieto J C, Amiranoff B, Dupont C, Hui Bon Hoa D, Rosselin G
Eur J Biochem. 1979 May 15;96(2):239-48. doi: 10.1111/j.1432-1033.1979.tb13034.x.
Porcine vasoactive intestinal peptide stimulated adenosine 3':5'-monophosphate (cyclic AMP) production in rat intestinal epithelial cells. The stimulation was dependent on time and temperature and was potentiated by the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine. Under optimal conditions (at 15 degrees C, with 0.2 mM 3-isobutyl-1-methylaxanthine, at a cell concentration up to 18 microgram DNA/ml), the cyclic AMP production produced by vasoactive intestinal peptide was constant for 10 min and stopped after 15 min incubation, at either low (1 nM) or high (30 nM) concentration of the peptide. This plateau effect was demonstrated not to be due to an inactivation of vasoactive intestinal peptide in the medium nor to an alteration of receptors for the peptide. Cyclic AMP production was sensitive to a concentration as low as 0.1 nM vasoactive intestinal peptide. Maximal stimulation of cyclic AMP levels by vasoactive intestinal peptide was observed with 30 nM vasoactive intestinal peptide and represented an 11-fold increased above basal. The dorse-response curve was monophasic with a Km of 2.3 x 10(-9) M. No cooperative effects were detected by Hill analysis. The positive non-linear relationship observed between stimulation of cyclic AMP production and occupancy of binding site was not time-dependent as indicated by experiments performed after 15, 45 and 120 min incubation. Maximal and half-maximal responses were obtained at about 70% and 7% occupation of binding sites, respectively. Chicken vasoactive intestinal peptide and porcine secretin were agonists of porcine vasoactive intestinal peptide with a 6-times and a 120-times lower potency, respectively. Among secretin analogs that were found to have low affinity for vasoactive intestinal peptide binding sites, [4-alanine, 5-valine]secretin, that resembles vasoactive intestinal peptide at the first seven amino acids at the N-terminal end, was a partial agonist of vasoactive peptide at the first seven amino acids at the N-terminal end, was a partial agonist of vasoactive intestinal peptide and others failed to stimulate cyclic AMP production. Glucagon (10microM), gastric inhibitory peptide (0.1 microM), substance, P, neurotensin, octapeptide of cholecystokinin, bovine pancreatic polypeptide, human gastrin I with leucine at residue 15, Leu-enkephalinand somatostatin (1 microM) did not alter cyclicAMP levels. Non-peptide mediators such as dopamine, serotonin, acetylcholine and histamine, tested at 10 microM, were also ineffective. Prostaglandins E2, E1 and isoproterenol, tested at 10 microM, induced an increase of cyclic AMP levels above basal but were 9.5, 13.7 and 17.5 times less efficient than vasoactive intestinal peptide, respectively. Thus vasoactive intestinal peptide is a unique stimulus of cyclic AMP production in rat intestinal epithelial cells.
猪血管活性肠肽可刺激大鼠肠上皮细胞中3':5'-环磷酸腺苷(环磷酸腺苷)的产生。这种刺激作用取决于时间和温度,并且磷酸二酯酶抑制剂3-异丁基-1-甲基黄嘌呤可增强该作用。在最佳条件下(15℃,含0.2 mM 3-异丁基-1-甲基黄嘌呤,细胞浓度高达18微克DNA/ml),无论肽的浓度是低(1 nM)还是高(30 nM),血管活性肠肽所产生的环磷酸腺苷在10分钟内保持恒定,孵育15分钟后停止。这种平台效应并非由于培养基中血管活性肠肽失活或肽受体改变所致。环磷酸腺苷的产生对低至0.1 nM的血管活性肠肽浓度敏感。用30 nM血管活性肠肽可观察到环磷酸腺苷水平的最大刺激,比基础水平增加了11倍。剂量-反应曲线是单相的,Km为2.3×10⁻⁹ M。通过希尔分析未检测到协同效应。如在孵育15、45和120分钟后进行的实验所示,环磷酸腺苷产生刺激与结合位点占据之间观察到的正非线性关系不依赖于时间。最大反应和半最大反应分别在结合位点占据约70%和7%时获得。鸡血管活性肠肽和猪促胰液素是猪血管活性肠肽的激动剂,效力分别低6倍和120倍。在发现对血管活性肠肽结合位点亲和力低的促胰液素类似物中,[4-丙氨酸,5-缬氨酸]促胰液素在N端前七个氨基酸与血管活性肠肽相似,是血管活性肠肽的部分激动剂,而其他类似物未能刺激环磷酸腺苷的产生。胰高血糖素(10微摩尔)、胃抑制肽(0.1微摩尔)、P物质、神经降压素、胆囊收缩素八肽、牛胰多肽、第15位残基为亮氨酸的人胃泌素I、亮氨酸脑啡肽和生长抑素(1微摩尔)均未改变环磷酸腺苷水平。在10微摩尔浓度下测试的非肽介质如多巴胺、5-羟色胺、乙酰胆碱和组胺也无效。在10微摩尔浓度下测试的前列腺素E2、E1和异丙肾上腺素可使环磷酸腺苷水平高于基础水平增加,但效率分别比血管活性肠肽低9.5、13.7和17.5倍。因此,血管活性肠肽是大鼠肠上皮细胞中环磷酸腺苷产生的独特刺激物。